http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3629327-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46efb3dcc7564d78c81e62a7b66b939f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-005
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
filingDate 1968-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1971-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19a6329d779b9aea3113d60004ecfb63
publicationDate 1971-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-3629327-A
titleOfInvention Lithium salt of hydroquinone sulfonic acid
abstract THE LITHIUM SALT OF HYDROQUINONE SULFONIC ACID OF THE FORMULA 1,4-DI(HO-),2-(LI-O3S-)BENZENE HAS THERAPEUTIC VALUE FOR NORMALIZING OR REDUCING THE ABNORMAL PERMEABILITY OF THE CAPILLARY WALL OF BLOOD VESSELS OF A PERSON OR ANIMAL HAVING CAPILLAR FRAGILITY, AND ALSO FOR TREATING INFECTIONS RELATIVE TO BLOOD COAGULATION. THIS NOVEL SALT CAN BE PREPARED BY REACTING P-BENZOQUINONE WITH LITHIUM BISULFITE IN A SOLVENT, OR BY REACTING THE POTASSIUM SALT OF HYDROQUINONE SULFONIC ACID WITH A LITHIUM SALT OF AN INORGANIC OR ORGANIC ACID IN A SOLVENT WHEREIN THE LITHIUM SALT OF HYDROQUINONE SULFONIC ACID IS SOLUBLE AND WHEREIN THE POTASSIUM SALT FORMED AS A BY-PRODUCT IS SLIGHTLY OR NOT SOLUBLE.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4038390-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10632085-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009083940-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3947448-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009083940-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10052294-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9227928-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9801838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9012692-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011144337-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2745914-A2
priorityDate 1967-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22003406
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136081648

Total number of triples: 29.